Handheld Surgical Devices Market Size

Global Handheld Surgical Devices Market Overview

Handheld Surgical Devices Market size was valued at USD 5.82 billion in 2022. The Handheld Surgical Devices Market industry is projected to grow from USD 6.28 billion in 2023 to USD 12.46 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.42% during the forecast period (2023 - 2032).

The growing prevalence of chronic disorders, such as cardiovascular, neurological, urological, and infectious diseases and increasing use of handheld devices in minimally invasive surgeries are major factors driving the growth of the Handheld Surgical Devices Market.

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

In April 2024, NICO Corporation will introduce the Myriad SPECTRA System, a technology designed for the precise surgical removal of high-grade glioma brain tumors using fluorescence guidance. The novel portable technology is specifically engineered to aid surgeons in the fluorescence-guided excision of Grade III and IV gliomas. When used with suitable surgical microscopes, it has the ability to provide white light to enhance the visibility of tumors and clots, as well as blue light to assist in the surgical removal of gliomas using fluorescence guidance. The Myriad SPECTRA System provides a distinct blend of lighting, removal, gathering, and conservation of biological tissue. This technique is suitable for surgeries that aim to treat brain tumors and intracerebral hemorrhages (ICH), which are regarded as the most severe and expensive types of strokes. The device is capable of accommodating both minimally invasive and open craniotomy surgical methods. NICO intends to introduce the device during the forthcoming American Association of Neurosurgical Surgeons (AANS) Annual Scientific Meeting in Chicago. The device's versatile features enable surgeons to seamlessly transition between full-spectrum white light and additional blue excitation light, improving the surgical view while maintaining the precise positioning of surgical optics. It has recently obtained approval from the US Food and Drug Administration and is also officially authorized for sales and clinical usage by the UK’s Medicines and Healthcare products Regulatory Agency.

In August 2023, GE HealthCare introduced the Vscan Air SL, a handheld ultrasound device, at the European Society of Cardiology (ESC) Congress in Amsterdam, the Netherlands. This device combines proprietary image enhancing technology and the capability to perform both vascular and cardiac assessments at the point of care. GE HealthCare stated that the Vscan Air SL, a handheld ultrasound instrument, has improved sensitivity and resolution by utilizing the exclusive SignalMax and XDclear technology. According to GE HealthCare, the Vscan Air SL has a dual-headed probe that allows physicians to access sector and linear arrays on the same device. This capacity makes it easier for clinicians to quickly analyze the vascular and heart health of patients. The increasing potency of portable ultrasound devices is revolutionizing patient treatment. Whether in a hospital ward or in a general practice setting, the ability to deliver imaging of excellent quality at the location where healthcare is provided is crucial for prompt diagnosis and treatment. 

Handheld Surgical Devices Trends

• The growing prevalence of chronic disorders, such as cardiovascular, neurological, urological, and infectious diseases fuels market growth

Chronic diseases such as cardiovascular, neurological, urological, and infectious diseases are increasing globally. Heart disorders are becoming more common than other chronic diseases due to a lack of physical activity, being overweight, smoking, poor nutrition, or having a family history. Furthermore, diabetes, hypertension, and hyperlipidemia are all risk factors for cardiovascular disease. For instance, according to the Centers for Disease Control and Prevention (CDC), approximately 20.1 million adults aged 20 and older had coronary artery disease in 2020. People over the age of 60 are at a higher risk of developing diseases such as cardiovascular, orthopedic, and neurological issues. Some people with these conditions or diseases have to undergo surgery. Therefore, an increase in cardiovascular, orthopedic, and neurological issues is expected to boost the demand for handheld surgical devices. The use of high-quality devices by surgeons is a constant priority in order to execute surgeries efficiently and quickly without compromising the health of the patient. Therefore, variables that are causing a surge in the need for handheld surgical devices include the rising prevalence of chronic conditions like cardiovascular, neurological, urological, and infectious diseases.

Handheld Surgical Devices Segment Insights

Handheld Surgical Devices Product Type Insights

The Handheld Surgical Devices Market segmentation, based on product type, includes graspers, retractors, mechanical cutters, suction tips and tubes, irrigation and injection needs, scopes and probes, sutures, forceps, tweezers, and others. The forceps segment held the majority share in the market in 2022. Surgical forceps are grasping-type surgical devices used for clamping, tweezing, and applying pressure during surgeries and other procedures. They can have either tweezer-style handles or ring handles used to hold or grasp tissue, dressings, or other objects. There are two primary types of surgical forceps, including locking forceps and non-locking forceps. Surgical forceps are important handheld surgical devices commonly made of high-grade carbon steel.

Handheld Surgical Devices Application Insights

The Handheld Surgical Devices Market segmentation, based on application, includes orthopedic surgery, ophthalmology, cardiology, wound care, urology and gynecology surgery, plastic surgery, thoracic surgery, neurosurgery and others. The orthopedic surgery segment dominated the market in 2022. There is an increasing number of orthopedic surgeries around the globe. Knee and hip replacements are some of the most commonly performed and effective surgeries around the globe. For instance, according to the American College of Rheumatology, over 450,000 hip replacement surgeries and around 790,000 total knee replacement surgeries are performed per year in the US. These increasing numbers of orthopedic surgeries are creating demand for orthopedic handheld surgical devices worldwide.

Handheld Surgical Devices End User Insights

The Handheld Surgical Devices Market segmentation, based on end user, includes hospitals & clinics, ambulatory surgical centers and others. The hospital & clinics segment dominated the market in 2022. A majority of the people in developing regions such as China and India prefer hospitals & clinics as advanced treatment for various chronic diseases such as cardiovascular diseases, diabetes, cancer, and others. According to the Center for Disease Control and Prevention in 2019, the prevalence of chronic diseases in adults was around 60% globally, and it is reportedly much higher among elderly people. It is estimated that about 70% of adults will die of one or more chronic diseases. Handheld surgical devices are used in various surgical applications for these chronic diseases. The rising prevalence of cardiovascular and other chronic disorders has further driven the growth of the segment.

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Handheld Surgical Devices Regional Insights

By Region, the study segments the market into North America, Europe, Asia-Pacific, and Rest of the World. The North America handheld surgical devices market accounted for the largest market share in 2022. The North America regional market is the largest market in terms of revenue. The market is driven by the increasing prevalence of cardiovascular, cancer, neurological, and autoimmune disorders in this region. Some common surgeries in this region include circumcision, gallbladder removal, angioplasty, C-section, cataract removal, joint replacement, broken bone repair, and cardiovascular disorders. For instance, according to a research article published in the Journal of the American Medical Association, the US had more than 13 million US surgical procedures from 2019 to 2021. Thus, such volume of surgeries promotes greater consumption of the market products.

Further, the major countries will be study are: The US, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3: HANDHELD SURGICAL DEVICES MARKET BY REGION 2022 & 2032 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe handheld surgical devices market accounted for the second-largest market share due to the growing demand for safe surgical devices that are used in minimally invasive surgeries, rising research and development investments, and increasing geriatric population. Furthermore, the Germany handheld surgical devices market attributed to hold the largest market share, and the France handheld surgical devices market is projected be the fastest growing market in the Europe region.

The Asia-Pacific handheld surgical devices market is expected to be the fastest growing from 2023 to 2032 due to the growing population, the increasing spending power of consumers, and the high prevalence of chronic disorders. Moreover, China handheld surgical devices market accounted to hold the largest market share, and the India handheld surgical devices market is projected to be the fastest growing market in the Asia-Pacific region.

Handheld Surgical Devices Key Market Players & Competitive Insights

Major market players’ growth is dependent on market conditions, government support, and industry development. The Handheld Surgical Devices Market is extremely competitive, with players competing, partnering, and investing heavily in research and development to gain a significant market share. The market is moderately fragmented with rising competition, product launches, increasing collaborative partnerships, and other strategic decisions to achieve operational efficiency.

Integra Lifesciences Holdings Corporation (US) is a medical technology company. The key focus of the company is to provide patients with a high level of satisfaction. Integra LifeSciences provides and operates innovative solutions in the field of orthopedic extremity surgery, neurosurgery, and reconstructive & general surgery. Integra Life Sciences is one of the leading providers of surgical devices and instruments to various hospitals, surgery centers, physicians, and dental offices, in the US.

Moreover, In December 2022, Integra LifeSciences announced the acquisition of the Surgical Innovation Association (US). As per the agreement Integra paid USD 50 m at the closing of the deal, as well as up to USD 90 million more upon reaching some revenue as well as regulatory milestones.

Key Companies in the handheld surgical devices market includes.

• Zimmer Biomet Holdings Inc. (US)


• Braun Melsungen AG (Germany)


• Becton, Dickinson and Company (US)


• Medline Industries Inc. (US)


• Peter Surgical (France)


• Medtronic Plc (Ireland)


• Abbott (US)


• Boston Scientific Corporation (US)


• Stryker (US)


• Smith & Nephew (UK)


• Coloplast Corp. (Denmark)


• Terumo Medical Corporation (Japan)


• Integra Lifesciences Holdings Corporation (US) Olympus Corporation (Japan)


• Johnson & Johnson Services, Inc. (US)

Handheld Surgical Devices Industry Developments

September 2023:Medline Industries Inc. (US) launched REFLEX TETRA Nitinol Staples at AOFAS 2023 Annual Meeting.  REFLEX TETRA four-leg staples are designed to fit the unique bone structures and anatomies of the MTP (metatarsophalangeal), first and lesser TMT (tarsometatarsal), and TN (talonavicular) joints

April 2023:Smith & Nephew (UK) introduces robotically enabled total knee arthroplasty CORI Digital Tensioner.  The purpose-built device that lets surgeons measure the ligament tension in a knee before cutting bone.

January 2023:Zimmer Biomet (US) has acquired Embody, Inc. (US), a privately held medical device company. The acquisition encompasses Embody's entire range of collagen-based biointegrative solutions, including TAPESTRY RC, one of the first arthroscopic implant systems for rotator cuff repair, and the biointegrative implant TAPESTRY for tendon healing, which support healing in the most challenging orthopedic soft tissue injuries.

Handheld Surgical Devices Segmentation

Handheld Surgical Devices Product Type Outlook

• Graspers


• Retractors


• Mechanical Cutters


• Suction Tips and Tubes


• Irrigation and Injection Needs


• Scopes and Probes


• Sutures


• Forceps


• Tweezers


• Others

Handheld Surgical Devices Application Outlook

• Orthopaedic Surgery


• Ophthalmology


• Cardiology


• Wound Care


• Urology and Gynecology Surgery


• Plastic Surgery


• Thoracic Surgery


• Neurosurgery


• Others

Handheld Surgical Devices End User Outlook

• Hospitals & Clinics


• Ambulatory Surgical Centers


• Others

Handheld Surgical Devices Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America